Advisory Research Inc. raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 45.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 70,628 shares of the biopharmaceutical company’s stock after purchasing an additional 22,097 shares during the quarter. Advisory Research […]
JW Asset Management LLC acquired a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) during the 4th quarter, HoldingsChannel reports. The firm acquired 563,392 shares of the biopharmaceutical company’s stock, valued at approximately $10,479,000. Catalyst Pharmaceuticals makes up 4.3% of JW Asset Management LLC’s investment portfolio, making the stock its 2nd biggest holding. […]
Jupiter Asset Management Ltd. increased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 1.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,245 shares of the biopharmaceutical company’s stock after purchasing an additional 879 shares during […]
Sawgrass Asset Management LLC increased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 113.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,786 shares of the biopharmaceutical company’s stock after acquiring an additional 12,133 shares during the […]
Hancock Whitney Corp purchased a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,818 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Several other large investors have also recently […]